Sanara MedTech (SMTI) Operating Leases (2019 - 2026)

Sanara MedTech's Operating Leases history runs 8 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• Quarterly Operating Leases rose 62.31% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 62.31% YoY) and the FY2025 annual result came in at $1.9 million, up 51.06% from the prior year.
• Operating Leases was $2.1 million for Q1 2026 at Sanara MedTech, up from $1.9 million in the prior quarter.
• Across five years, Operating Leases topped out at $2.1 million in Q1 2026 and bottomed at $151378.0 in Q2 2022.
• A 5-year average of $1.4 million and a median of $1.7 million in 2023 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2022 — Operating Leases plunged 63.88% — and 2023, when it jumped 1256.18%.
• Sanara MedTech's Operating Leases stood at $505291.0 in 2022, then surged by 243.85% to $1.7 million in 2023, then retreated by 28.8% to $1.2 million in 2024, then jumped by 51.06% to $1.9 million in 2025, then grew by 14.45% to $2.1 million in 2026.
• Business Quant data shows SMTI's Operating Leases at $2.1 million in Q1 2026, $1.9 million in Q4 2025, and $2.0 million in Q3 2025.